IRIS Accounts Production v25.1.0.734 03106011 Board of Directors 1.8.23 31.7.24 31.7.24 false true false false false true false Ordinary 1.00000 Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh031060112023-07-31031060112024-07-31031060112023-08-012024-07-31031060112022-07-31031060112022-08-012023-07-31031060112023-07-3103106011ns15:EnglandWales2023-08-012024-07-3103106011ns14:PoundSterling2023-08-012024-07-3103106011ns10:Director12023-08-012024-07-3103106011ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3103106011ns10:SmallEntities2023-08-012024-07-3103106011ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3103106011ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3103106011ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3103106011ns10:FullAccounts2023-08-012024-07-310310601112023-08-012024-07-3103106011ns10:OrdinaryShareClass12023-08-012024-07-3103106011ns10:Director22023-08-012024-07-3103106011ns10:CompanySecretary12023-08-012024-07-3103106011ns10:RegisteredOffice2023-08-012024-07-3103106011ns5:CurrentFinancialInstruments2024-07-3103106011ns5:CurrentFinancialInstruments2023-07-3103106011ns5:Non-currentFinancialInstruments2024-07-3103106011ns5:Non-currentFinancialInstruments2023-07-3103106011ns5:ShareCapital2024-07-3103106011ns5:ShareCapital2023-07-3103106011ns5:RetainedEarningsAccumulatedLosses2024-07-3103106011ns5:RetainedEarningsAccumulatedLosses2023-07-3103106011ns5:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3103106011ns5:FurnitureFittings2023-08-012024-07-3103106011ns5:ComputerEquipment2023-08-012024-07-3103106011ns5:IntangibleAssetsOtherThanGoodwill2023-07-3103106011ns5:IntangibleAssetsOtherThanGoodwill2024-07-3103106011ns5:IntangibleAssetsOtherThanGoodwill2023-07-3103106011ns5:FurnitureFittings2023-07-3103106011ns5:ComputerEquipment2023-07-3103106011ns5:FurnitureFittings2024-07-3103106011ns5:ComputerEquipment2024-07-3103106011ns5:FurnitureFittings2023-07-3103106011ns5:ComputerEquipment2023-07-3103106011ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3103106011ns5:WithinOneYearns5:CurrentFinancialInstruments2023-07-3103106011ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-07-3103106011ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-07-3103106011ns5:Secured2024-07-3103106011ns5:Secured2023-07-3103106011ns10:OrdinaryShareClass12024-07-31
REGISTERED NUMBER: 03106011 (England and Wales)



















MILLBROOK MEDICAL
CONFERENCES LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2024






MILLBROOK MEDICAL
CONFERENCES LIMITED (REGISTERED NUMBER: 03106011)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024










Page

Company Information 1

Balance Sheet 2 to 3

Notes to the Financial Statements 4 to 7


MILLBROOK MEDICAL
CONFERENCES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JULY 2024







DIRECTORS: Mrs F L McDonald
Mr D J Legate





SECRETARY: Mr D J Legate





REGISTERED OFFICE: 81 Burton Road
Derby
Derbyshire
DE1 1TJ





REGISTERED NUMBER: 03106011 (England and Wales)





ACCOUNTANTS: Johnson Tidsall Limited
Chartered Accountants
81 Burton Road
Derby
Derbyshire
DE1 1TJ

MILLBROOK MEDICAL
CONFERENCES LIMITED (REGISTERED NUMBER: 03106011)

BALANCE SHEET
31 JULY 2024

2024 2023
Notes £    £    £   
FIXED ASSETS
Intangible assets 4 3,761 13,675
Tangible assets 5 22,712 18,099
26,473 31,774

CURRENT ASSETS
Debtors 6 457,089 282,005
Cash at bank and in hand 81,161 350,171
538,250 632,176
CREDITORS
Amounts falling due within one year 7 303,685 337,160
NET CURRENT ASSETS 234,565 295,016
TOTAL ASSETS LESS CURRENT LIABILITIES 261,038 326,790

CREDITORS
Amounts falling due after more than one year 8 (8,338 ) (18,338 )

PROVISIONS FOR LIABILITIES - (1,218 )
NET ASSETS 252,700 307,234

CAPITAL AND RESERVES
Called up share capital 10 2 2
Retained earnings 252,698 307,232
SHAREHOLDERS' FUNDS 252,700 307,234

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MILLBROOK MEDICAL
CONFERENCES LIMITED (REGISTERED NUMBER: 03106011)

BALANCE SHEET - continued
31 JULY 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 April 2025 and were signed on its behalf by:





Mr D J Legate - Director


MILLBROOK MEDICAL
CONFERENCES LIMITED (REGISTERED NUMBER: 03106011)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024


1. STATUTORY INFORMATION

Millbrook Medical Conferences Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoices sales of services, excluding value added tax.

Intangible assets
Development costs are being amortised evenly over their estimated useful life of two or ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on reducing balance

Tangible fixed assets are stated at cost less accumulated depreciation. Cost includes costs directly attributable to making the asset capable of operating as intended.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

MILLBROOK MEDICAL
CONFERENCES LIMITED (REGISTERED NUMBER: 03106011)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2024


2. ACCOUNTING POLICIES - continued

Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 15 (2023 - 11 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 August 2023
and 31 July 2024 35,515
AMORTISATION
At 1 August 2023 21,840
Charge for year 9,914
At 31 July 2024 31,754
NET BOOK VALUE
At 31 July 2024 3,761
At 31 July 2023 13,675

MILLBROOK MEDICAL
CONFERENCES LIMITED (REGISTERED NUMBER: 03106011)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2024


5. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 August 2023 37,591 44,653 82,244
Additions 808 10,235 11,043
At 31 July 2024 38,399 54,888 93,287
DEPRECIATION
At 1 August 2023 32,001 32,144 64,145
Charge for year 1,459 4,971 6,430
At 31 July 2024 33,460 37,115 70,575
NET BOOK VALUE
At 31 July 2024 4,939 17,773 22,712
At 31 July 2023 5,590 12,509 18,099

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 411,086 217,053
Other debtors 5,000 5,000
VAT 9,088 28,217
Prepayments and accrued income 31,915 31,735
457,089 282,005

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 10,000 10,000
Trade creditors 122,078 21,126
Corporation tax 3,002 42,593
Social security and other taxes 10,463 7,621
Other creditors 152,275 250,238
Directors' current accounts 732 602
Accruals and deferred income 5,135 4,980
303,685 337,160

MILLBROOK MEDICAL
CONFERENCES LIMITED (REGISTERED NUMBER: 03106011)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2024


8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loans - 2-5 years 8,338 18,338

9. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Bank loans 18,338 28,338

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
2 Ordinary £1 2 2

11. OTHER FINANCIAL COMMITMENTS

The company had total guarantees and commitments at the balance sheet date of £91,645 (2023: £134,880).

12. RELATED PARTY DISCLOSURES

Included in current liabilities is a loan from a director which has no fixed repayment terms and is interest free.